TrialMedicine2016

Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Guogan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.